Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMICUS THERAPEUTICS, INC. Director's Dealing 2011

Jan 19, 2011

31523_dirs_2011-01-19_86b0497d-8075-40f1-8be8-e0e3434a0557.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2011-01-03

Reporting Person: Peist Kenneth (VP, Intellectual Property)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 250 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (right to buy) $9.54 2017-12-10 Common Stock (12500) Direct
Stock Options (right to buy) $10.36 2019-02-03 Common Stock (11000) Direct
Stock Options (right to buy) $4.16 2019-11-16 Common Stock (25000) Direct
Stock Options (right to buy) $3.32 2020-03-16 Common Stock (10000) Direct
Stock Options (right to buy) $2.81 2020-06-15 Common Stock (8000) Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on December 10, 2008. The remaining options vest and become exercisable in a series of thirty-six equal installments, beginning on January 1, 2009.

F2: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on February 3, 2010. The remaining options vest and become exercisable in a series of thirty-six equal installments, beginning on March 1, 2010.

F3: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on November 16, 2010. The remaining options vest and become exercisable in a series of thirty-six equal installments, beginning on December 1, 2010.

F4: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, will vest on March 16, 2011. The remaining options will vest and become exercisable in a series of thirty-six equal installments, beginning on April 1, 2011.

F5: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, will vest on June 15, 2011. The remaining options will vest and become exercisable in a series of thirty-six equal installments, beginning on July 1, 2011.